<DOC>
	<DOCNO>NCT01283230</DOCNO>
	<brief_summary>This prospective cohort Study evaluation liver fibrosis stag acoustic radiation force impulse elastography patient chronic liver disease healthy liver/kidney donor .</brief_summary>
	<brief_title>Evaluation Liver Fibrosis Staging With Acoustic Radiation Force Impulse Elastography</brief_title>
	<detailed_description>A recent new method liver fibrosis assessment base similar technology transient elastography acoustic radiation force impulse ( ARFI ) imaging . ARFI advantage conduct parallel way measure point patient chronic liver disease underwent routine ultrasound examination . Thus , aim study identify normal range ARFI velocity ass best cut-off value recruit healthy living liver kidney donor .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Age &gt; 20 year chronic liver disease ( hepatitis B , hepatitis C , liver cirrhosis ) patient plan liver biopsy Healthy liver kidney donor The patient willing able provide write informed consent participate study Decompensated liver cirrhosis Patients liver congestion due heart dysfunction Patients previously take antiviral agent antifibrotic agent Healthy liver kidney donor laboratory abnormality regard liver condition ( Platelet count &lt; 150 x 103/ul , Fasting glucose &gt; 110 mg/dl , AST &gt; 40 IU/L , ALT &gt; 40 IU/L , Albumin &lt; 3.3 g/dl , Total bilirubin &gt; 1.2 mg/dl , GGT &gt; 54 IU/L , ALP &gt; 115 IU/L , Ferritin &gt; 322 ng/ml ) A history medical disease condition would make patient unsuitable study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>ARFI imaging</keyword>
	<keyword>normal value</keyword>
	<keyword>chronic liver disease</keyword>
	<keyword>liver donor</keyword>
	<keyword>kidney donor</keyword>
</DOC>